Items tagged with Global health
In this guest post, Claire Wingfield—product development policy officer at PATH—writes about a new paper exploring why research and development (R&D) of high-priority health tools for diseases and conditions affecting low- and middle-income countries (LMICs) should be a critical component of the post-2015 development agenda.
How a new funding model will shift allocations from the Global Fund to Fight AIDS, Tuberculosis and Malaria (post)
The European Medicines Agency (EMA) supports European Antibiotic Awareness Day (EAAD), which is taking place on Tuesday 18 November. EAAD is organised every year by the European Centre for Disease Prevention and Control (ECDC). It aims to raise awareness of the threat to public and animal health of antimicrobial resistance and the importance of prudent use of antibiotics.
Congress adds $300 million to PEPFAR for FY15, in bill global health advocates say recognizes critical needs (post)
The world’s largest humanitarian and health program dedicated to defeating a single disease will have more to work with in the coming year, with a Congressional spending bill released Tuesday that increases, or maintains from last year’s allocations almost all areas of global health spending for fiscal year 2015. The bill includes a $300 million increase for the President’s Emergency Plan for AIDS Relief over the amount allotted for fiscal year 2014, and over the amount requested by President Obama in his FY15 proposed budget. The allotment of $4.3 billion for PEPFAR restores half of the $600 million in cuts PEPFAR has seen since 2011.
SEATTLE—People are living much longer worldwide than they were two decades ago, as death rates from infectious diseases and cardiovascular disease have fallen, according to a new, first-ever journal publication of country-specific cause-of-death data for 188 countries.
When the outbreak of Ebola in West African spiraled out of control in the middle of 2014, health-care advocates pointed to it as a reason why countries like the United States need to engage in health globally. There are many other problems that affect more people than Ebola and that also pose a threat to Americans. It all comes at a time when the United States is making cuts to vital research and development supporting drugs and vaccines for neglected tropical diseases, say advocates.
At high profile India US CEO meeting, President Obama calls for tougher intellectual property protection despite deadly impact on public health (post)
Press Statement: For Immediate Release: January 27 2015
Contact: Matthew Kavanagh, +1 202-486-2488, email@example.com
Asia Russell, +1 267 475 2645, firstname.lastname@example.org
It is no secret that the United States has been scaling up pressure on India to adopt intellectual property measures similar to those common in the United States and the European Union. But to what extent does India’s new government led by the business-friendly Narendra Modi see eye to eye with US official position? Can India, the “pharmacy of the world”, resolve the friction between pharmaceutical patents and access to affordable medicines without putting off foreign investors? The vitriolic and polarising debate surrounding these questions has got a fresh lease of life following US President Barack Obama’s landmark three-day visit to India this week.
In search of sustainable innovation models for cures for diseases affecting primarily developing countries, with the Ebola epidemic as a new reminder of the necessity and urgency of the matter, the World Health Organization had tasked an expert working group with the search for solutions. Last week, the WHO Executive Board took note of the progress made so far.
White House FY 16 budget proposal cuts PEPFAR, cuts $45 million — 19 percent — from current TB funding (post)
Efforts to fight HIV and tuberculosis globally would work with less money overall in fiscal year 2016 under the President’s newly released budget proposal.
Page 2 of 11 · Total posts: 0←First 1 2 3 Last→